Prof Tomasz Guzik is a Chair of Cardiovascular Medicine at the University of Edinburgh, UK, and a Professor of Medicine at Jagiellonian University in Krakow, Poland. His research focuses on understanding how inflammation and oxidation intersect in vascular biology, especially in the context of hypertension. His group's most important contributions include understanding the mechanisms of oxidative stress and vascular dysfunction in humans (Circ Res, 2000; Circulation, 2002; JACC; 2008; J Clin Invest, 2022) and, more recently, the defining novel role of inflammation and adaptive immunity in hypertension (J Exp Med, 2007; Circulation, 2020; Circ Res, 2020). His most recent work focused on identifying neuroimmune reflexes controlling atherosclerosis (Nature, 2022) and defining mechnaisms of increased vascular risk following breast cancer chemotherapy (J Clin Invest, 2022).
In 2021 and 2022 he was recognised as a Highly Cited Scientist by Clarivate. He published over 250 original studies with top cited papers receiving >1000 citations (WoS H factor – 66; with a total of 18900 citations). Prof Guzik received several international awards for research excellence including Arthur Corcoran Award in Hypertension (AHA) and JJ Marshal Award in Cardiovascular Research (BSCR).
His group is currently funded primarily by the European Research Council, European Commission, and the British Heart Foundation.
He serves on Editorial boards of several Journals, including the European Heart Journal, Circulation Research, and Hypertension. Prof Guzik is an Editor-in-Chief of Cardiovascular Research, serves as a board member of the European Society of Cardiology, is Chairperson of the European Society of Cardiology Research and EU Grants Committee, and a treasurer of the British Atherosclerosis Society.